Total Payments
$8,576
2024 Payments
$810.56
Companies
35
Transactions
398
Medicare Patients
15,685
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$7,280 (84.9%)
Travel$1,290 (15.0%)
Education$6.25 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,280 | 394 | 84.9% |
| Travel and Lodging | $1,290 | 3 | 15.0% |
| Education | $6.25 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,642 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $920.88 | 60 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $674.48 | 49 | $0 (2023) |
| PFIZER INC. | $651.15 | 45 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $619.48 | 40 | $0 (2024) |
| Amgen Inc. | $608.31 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $413.76 | 22 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $387.15 | 29 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $376.24 | 25 | $0 (2023) |
| Medtronic, Inc. | $252.15 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $810.56 | 20 | Boston Scientific Corporation ($130.60) |
| 2023 | $3,075 | 88 | Edwards Lifesciences Corporation ($1,387) |
| 2022 | $1,706 | 98 | E.R. Squibb & Sons, L.L.C. ($283.46) |
| 2021 | $937.38 | 52 | Boehringer Ingelheim Pharmaceuticals, Inc. ($198.54) |
| 2020 | $161.88 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($30.06) |
| 2019 | $793.16 | 57 | Novartis Pharmaceuticals Corporation ($213.75) |
| 2018 | $795.23 | 54 | Novartis Pharmaceuticals Corporation ($220.60) |
| 2017 | $297.53 | 18 | Novartis Pharmaceuticals Corporation ($92.13) |
All Payment Transactions
398 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $130.60 | General |
| Category: WATCHMAN Pro_IC | ||||||
| 11/26/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.22 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $123.87 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Obesity | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.98 | General |
| Category: Cardiovascular | ||||||
| 09/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $119.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/29/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/21/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Cardiology | ||||||
| 05/07/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $125.20 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/27/2023 | Edwards Lifesciences Corporation | PASCAL (Device) | Travel and Lodging | In-kind items and services | $305.85 | General |
| Category: Transcatheter Valve Repair | ||||||
| 12/14/2023 | Edwards Lifesciences Corporation | PASCAL (Device) | Travel and Lodging | In-kind items and services | $258.77 | General |
| Category: Transcatheter Valve Repair | ||||||
| 12/14/2023 | Edwards Lifesciences Corporation | PASCAL (Device) | Food and Beverage | In-kind items and services | $78.31 | General |
| Category: Transcatheter Valve Repair | ||||||
| 12/05/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardiology | ||||||
| 11/20/2023 | Edwards Lifesciences Corporation | PASCAL (Device) | Travel and Lodging | In-kind items and services | $725.69 | General |
| Category: Transcatheter Valve Repair | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,779 | 5,020 | $1.1M | $283,107 |
| 2022 | 25 | 4,695 | 6,416 | $1.5M | $380,086 |
| 2021 | 26 | 4,172 | 5,715 | $1.4M | $378,574 |
| 2020 | 25 | 3,039 | 4,109 | $761,967 | $290,026 |
Total Patients
15,685
Total Services
21,260
Medicare Billing
$1.3M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 582 | 857 | $342,702 | $81,028 | 23.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 227 | 552 | $203,688 | $54,904 | 27.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 148 | 149 | $93,274 | $23,918 | 25.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 409 | 411 | $86,316 | $23,203 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 125 | 125 | $65,250 | $16,295 | 25.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 97 | 98 | $52,626 | $14,083 | 26.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 652 | 981 | $45,126 | $10,704 | 23.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 23 | 51 | $33,762 | $9,248 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 62 | 62 | $25,668 | $6,904 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 37 | 46 | $20,378 | $5,464 | 26.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 560 | 813 | $21,138 | $5,463 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 57 | 62 | $18,724 | $5,050 | 27.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 36 | $20,160 | $4,804 | 23.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $14,612 | $4,004 | 27.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 42 | 42 | $9,786 | $2,565 | 26.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 27 | 27 | $9,072 | $2,377 | 26.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $6,868 | $1,879 | 27.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 106 | 106 | $6,890 | $1,821 | 26.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 19 | 19 | $6,156 | $1,686 | 27.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 25 | $6,150 | $1,679 | 27.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 76 | 79 | $6,004 | $1,622 | 27.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 117 | 117 | $5,031 | $1,299 | 25.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 53 | 53 | $4,187 | $1,110 | 26.5% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 53 | 53 | $2,120 | $546.92 | 25.8% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 69 | 70 | $1,540 | $414.69 | 26.9% |
About Dr. Matthew Peters, MD
Dr. Matthew Peters, MD is a Cardiovascular Disease healthcare provider based in Reisterstown, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2011. The National Provider Identifier (NPI) number assigned to this provider is 1588956304.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Peters, MD has received a total of $8,576 in payments from pharmaceutical and medical device companies, with $810.56 received in 2024. These payments were reported across 398 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,280).
As a Medicare-enrolled provider, Peters has provided services to 15,685 Medicare beneficiaries, totaling 21,260 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Reisterstown, MD
- Active Since 05/12/2011
- Last Updated 10/21/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1588956304
Products in Payments
- PASCAL (Device) $1,369
- ENTRESTO (Drug) $891.59
- ELIQUIS (Drug) $784.04
- XARELTO (Drug) $640.55
- Repatha (Biological) $457.13
- LifeVest (Device) $387.15
- Vascepa (Drug) $228.81
- FARXIGA (Drug) $206.14
- CAMZYOS (Drug) $204.84
- BRILINTA (Drug) $153.92
- Corlanor (Drug) $151.18
- FUROSCIX (Drug) $145.57
- ONYX FRONTIER (Device) $139.75
- VYNDAQEL (Drug) $137.87
- WATCHMAN (Device) $130.60
- GALLANT (Device) $125.20
- AREXVY (Drug) $123.87
- UBRELVY (Drug) $119.60
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $118.19
- Arcalyst (Drug) $114.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.